Skip to main content
SpringerLink
Log in

Wolff-Parkinson-White Syndrome

Identification and Management

  • Practical Therapeutic
  • Published:
Drugs Aims and scope Submit manuscript

Summary

Patients with Wolff-Parkinson-White (WPW) pattern of ventricular pre-excitation may develop paroxysmal re-entrant tachyarrhythmias through the Kent bundle and, less commonly, atrial fibrillation. WPW patients are at risk of sudden death when a rapid ventricular response occurs during atrial fibrillation due to conduction through the accessory pathway. Conduction properties of the accessory pathway and atrial vulnerability, which is the propensity to develop atrial fibrillation, are important parameters for evaluation in these patients. The former can be assessed by means of noninvasive tests, such as stress and pharmacological tests, and with electrophysiological study; the latter only by electrophysiological study. There is no indication for treatment of asymptomatic patients. Antiarrhythmic prophylaxis is required in patients with previous episodes of atrial fibrillation with rapid ventricular response, in patients with paroxismal re-entrant tachycardias and rapid conduction through the accessory pathway, and in patients with frequent episodes of re-entrant tachycardias of long duration. Vaughan-Williams class IC antiarrhythmic drugs (propafenone, flecainide) are the first choice for drugs in patients with rapid anterograde conduction through the accessory pathway due to their high efficacy and low incidence of adverse effects, while β-blockers (atenolol, nadolol) are indicated for patients with reentrant tachycardias and low conduction capacity through the bypass tract. When pharmacological therapy is ineffective, surgical or catheter ablation of the accessory pathway may be considered.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Bardy GH, Packer DL, German LD, Gallagher JJ. Pre-excited reciprocating tachycardia in patients with Wolff-Parkinson-White syndrome: incidence and mechanism. Circulation 70: 377–391, 1984

    Article  PubMed  CAS  Google Scholar 

  • Baurnfeind RA, Wyndham CR, Swyrn SP, Palileo EV, Strasberg B, et al. Paroxysmal atrial fibrillation in the Wolff-Parkinson-White syndrome. American Journal of Cardiology 47: 562–569, 1981

    Article  Google Scholar 

  • Berkman NL, Lamb LE. The Wolff-Parkinson-White syndrome electrocardiogram: a follow-up study of five to twenty years. New England Journal of Medicine 278: 492–494, 1968

    Article  PubMed  CAS  Google Scholar 

  • Bexton RS, Hellestrand KJ, Nathan AW, Spurrel RAJ, Camm AJ. A comparison of the antiarrhythmic effects on AV junctional re-entrant tachycardia or oral and intravenous flecainide acetate. European Heart Journal 4: 92–102, 1983

    PubMed  CAS  Google Scholar 

  • Borggrefe M, Hindriks G, Haverkamp W, Martinez-Rubio A, Karbenn U, et al. Radiofrequency ablation of supraventricular and atrioventricular tachyarrhythmias. In Santini M, et al. Progress in clinical pacing 1990; pp. 335–353, Excerta Medica, Amsterdam, 1990

    Google Scholar 

  • Breithardt B, Barggrefe M, Wiebringhans E, Seipel L. Effect of proprafenone in Wolff-Parkinson-White syndrome: electrophysiologic findings and long-term follow-up. American Journal of Cardiology 54: 29D-39D, 1984

    Article  Google Scholar 

  • Campbell RW, Smith RA, Gallagher JJ, Pritchett ELC, Wallace AG. Atrial fibrillation in the preexcitation syndrome. American Journal of Cardiology 40: 514–520, 1977

    Article  PubMed  CAS  Google Scholar 

  • Castillo-Fenoy A, Goupil A, Offenstadt G, Nguyen GK. Syndrome de Wolff-Parkinson-White et mort subite. Annales de Medicine Interne 124: 871–875, 1973

    CAS  Google Scholar 

  • Cox JL. Experience with 118 consecutive patients undergoing operation for Wolff-Parkinson-White syndrome. Journal of Thoracic and Cardiovascular Surgery 90: 490–501, 1985

    PubMed  CAS  Google Scholar 

  • Crick JCP, Davies DW, Holt P, Curry PBL, Sowton E. Effect of exercise on ventricular response to atrial fibrillation in Wolff-Parkinson-White syndrome. British Heart Journal 54: 80–85, 1985

    Article  PubMed  CAS  Google Scholar 

  • Critelli B, Gallagher JJ, Perticone F, Cortorti F, Monda V, et al. Evaluation of noninvasive tests for identifying patients with preexcitation syndrome at risk of rapid ventricular response. American Heart Journal 108: 905–909, 1984

    Article  PubMed  CAS  Google Scholar 

  • Dreifus LS, Haiat R, Watanabe Y, Arriaga J, Reitman R. Ventricular fibrillation: a possible mechanism of sudden death in patients with Wolff-Parkinson-White syndrome. Circulation 43: 520–527, 1971

    Article  PubMed  CAS  Google Scholar 

  • Eschar Y, Belhassen B, Laniado S. Comparison of exercise and ajmaline tests with electrophysiologic study in the Wolff-Parkinson-White syndrome. American Journal of Cardiology 57: 782–786, 1986

    Article  Google Scholar 

  • Fauchier JP, Cosnay P, Moquet B, Rouesnel P, Vrancea F. Etude de la propafenone injectable et orale dans les rentres nodales et les voies de preexcitation ventriculaire. Archives des Maladies du Coeur 79: 1506–1514, 1986

    CAS  Google Scholar 

  • Fauchier JP, Cosnay P, Rousnel P, Moquet B, Bonnet P, et al. Effets de la flécainide injectable et orale chez les patients avant una voie accessoire auriculo-ventriculaire. Archives des Maladies du Coeur 78 (Special): 81–90, 1985

    Google Scholar 

  • Flensted-Jensen E. Wolff-Parkinson-White syndrome: a long-term follow-up of 47 cases. Acta Medica Scandinavica 186: 65–74, 1969

    Article  PubMed  CAS  Google Scholar 

  • Frank R, Fontaine G, Guiraudon G, Cabrol C, Grosgogeat Y, et al. Corrélation entre l’orientation de l’onde delta et la topographie de la pré-excitation dans le sindrome de Wolff-Par-kinson-White. Archives des Maladies du Coeur 70: 441–450, 1977

    CAS  Google Scholar 

  • Gaita F, Giustetto C, Riccardi R, Mangirdi L, Brusca A. Stress and pharmacological test as methods to identify patients with Wolff-Parkinson-White syndrome at risk of sudden death. American Journal of Cardiology 64: 487–490, 1989a

    Article  PubMed  CAS  Google Scholar 

  • Gaita F, Giustetto C, Riccardi R, Mangiardi L, Brusca A. Electrophysiologic study in patients with Wolff-Parkinson-White at risk for sudden death. XI World Congress of Cardiology. Abstract. Phillippine Journal of Cardiology 1247, 1990a

  • Gaita F, Giustetto C, Riccardi R, Mangiardi L, Rosettani E, et al. Wolff-Parkinson-White syndrome: atrial vulnerability and electrophysiologic features in patients with and without atrial fibrillation. In Attuel P, et al. (Eds) The atrium in health and disease, pp. 203–212, Futura Publishing Company Inc., New York, 1989b

    Google Scholar 

  • Gaita F, Giustetto C, Riccardi R, Mazza A, Mangiardi L, et al. Relation between spontaneous atrial fibrillation and atrial vulnerability in patients with Wolff-Parkinson-White pattern. Pacing and Clinical Electrophysiology 13: 1249–1253, 1990b

    Article  PubMed  CAS  Google Scholar 

  • Gallagher JJ, Pritchett ELC, Sealy WC. The preexcitation syndrome. Progress in Cardiovascular Diseases 20: (4): 285–327, 1978

    Article  PubMed  CAS  Google Scholar 

  • German LD, Gallagher JJ, Brughton A, Guarnieri T, Trantham JL. Effects of exercise and isoproterenol during atrial fibrillation in patients with Wolff-Parkinson-White syndrome. American Journal of Cardiology 51: 1203–1206, 1983

    Article  PubMed  CAS  Google Scholar 

  • Giardina AL, Ehlers KH, Engle MA. Wolff-Parkinson-White syndrome in infants and children: a long-term follow-up study. British Heart Journal 34: 839–846, 1972

    Article  PubMed  CAS  Google Scholar 

  • Guiraudon GM, Klein GJ, Sharma AD. Surgery for Wolff-Parkinson-White syndrome using a closed heart technique: further experience and limitations. Abstract. Journal of American College of Cardiology 7: 133A, 1986

    Article  Google Scholar 

  • Guize L, Soria R, Chaouat JC, Chrétien JM, Houe D, et al. Prévalence et evolution du syndrome de Wolff-Parkinson-White dans une population de 138,048 sujets. Annales de Medecine Interne 136: 474–478, 1985

    PubMed  CAS  Google Scholar 

  • Gulamhusein S, Ko P, Carruthers G, Klein GJ. Acceleration of the ventricular response during atrial fibrillation in the Wolff-Parkinson-White syndrome after verapamil. Circulation 65: 348–354, 1982

    Article  PubMed  CAS  Google Scholar 

  • Harper RW, Whitford E, Middlebrook K, Federman J, Anderson S, et al. Effects of verapamil on the electrophysiologic properties of the accessory pathway in patients with the Wolff-Parkinson-White syndrome. American Journal of Cardiology 50: 1323–1330, 1982

    Article  PubMed  CAS  Google Scholar 

  • Harron DWG, Brogden RN. Propafenone. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in the treatment of arrhythmias. Drugs 34: 617–647, 1987

    Article  PubMed  CAS  Google Scholar 

  • Hiss RG, Lamb EL. Electrocardiographic findings in 122 043 individuals. Circulation 25: 947–961, 1962

    Article  PubMed  CAS  Google Scholar 

  • Holmes B, Heel RC. Flecainide. A preliminary review of its pharmacodynamic properties and therapeutic efficacy. Drugs 29: 1–33, 1985

    Article  PubMed  CAS  Google Scholar 

  • Jackman WM, Wang X, Friday KJ, Roman CJ, Moulton CP, et al. Catheter ablation of accessory atrioventricular pathways (Wolff-Parkinson-White syndrome) by radiofrequency current. New England Journal of Medicine 324: 1605–1611, 1991

    Article  PubMed  CAS  Google Scholar 

  • Kerr CR, Gallagher JJ, Smith WM, Sterba R, German LD, et al. The induction of atrial flutter and fibrillation and the termination of atrial flutter by esophageal pacing. Pacing and Clinical Electrophysiology 6: 60–72, 1983

    Article  PubMed  CAS  Google Scholar 

  • Klein GJ, Bashore TH, Sellers TD. Ventricular fibrillation in the Wolff-Parkinson-White syndrome. New England Journal of Medicine 301: 1080–1085, 1979

    Article  PubMed  CAS  Google Scholar 

  • Klein GJ, Bashore TH, Sellers TD. Ventriculr fibrillation in the Wolff-Parkinson-White syndrome. New England Journal of Medicine 301: 1080–1085, 1979

    Article  PubMed  CAS  Google Scholar 

  • Klein GJ, Gulamhusein SS. Intermittent preexcitation in the Wolff-Parkinson-White syndrome. American Journal of Cardiology 52; 292–296, 1983

    Article  PubMed  CAS  Google Scholar 

  • Ludmer PL, McGowan NE, Antman EM, Friedman PL. Efficacy of proprafenone in Wolff-Parkinson-White syndrome: electrophysiologic findings and long-term follow-up. Journal of American College of Cardiology 9: 1357–1363, 1987

    Article  CAS  Google Scholar 

  • Martin-Noel P, Denis B, Grundwald D. Deux cas mortels de syndrome de Wolff-Parkinson-White. Archives des Maladies du Coeur et des Vaisseaux 63; 1647–1656, 1970

    PubMed  CAS  Google Scholar 

  • Michelucci A, Padeletti L, Monizzi D, Porciani MC, Musante R, et al. Atrial electrophysiologic properties of patients with asymptomatic Wolff-Parkinson-White. European Heart Journal 9: 479–483, 1988

    PubMed  CAS  Google Scholar 

  • Orinius E. Preexcitation studies on criteria, prognosis and heredity. Acta Medica Scandinavica (Suppl.) 465: 5–50, 1966

    Google Scholar 

  • Przybylski J, Chiale PA, Halpern S, Nau GJ, Elizari MV, et al. Unmasking of ventricular preexcitation by vagal stimulation or isoproterenol administration. Circulation 61: 1030–1037, 1980

    Article  PubMed  CAS  Google Scholar 

  • Reiter MJ, Mann DE. Effects of upright posture on atrioventricular accessory pathway conduction. American Journal of Cardiology 65: 623–627, 1990

    Article  PubMed  CAS  Google Scholar 

  • Rinne C, Klein GJ, Sharma A, Yee R, Milstein S, et al. Relation between clinical presentation and induced arrhythmias in the Wolff-Parkinson-White syndrome. American Journal of Cardiology 60: 576–579, 1987

    Article  PubMed  CAS  Google Scholar 

  • Rosettani E, Giustetto C, Gaita F, Mangiardi L, Riccardi R, et al. Studio elettrofisiologico in clinoed in ortostatismo dei pazienti con Wolff-Parkinson-White. Giornale Italiano di Cardiologia 17(II): 569–574, 1987

    PubMed  CAS  Google Scholar 

  • Schiebler GL, Adamp F, Anderson RC. The Wolff-Parkinson-White syndrome in infants and children: a review and a report of 28 cases. Pediatrics 24: 585–603, 1959

    PubMed  CAS  Google Scholar 

  • Sellers DT, Bashore TM, Gallagher JJ. Digitalis in the pre-excitation syndrome: analysis during atrial fibrillation. Circulation 56: 260–267, 1977

    Article  PubMed  Google Scholar 

  • Sharma AD, Klein BJ, Guiraudon GM, Milstein S. Atrial fibrillation in patients with Wolff-Parkinson-White syndrome: incidence after surgical ablation of the accessory pathway. Circulation 72: 161–169, 1985

    Article  PubMed  CAS  Google Scholar 

  • Sharma AD, Yee R, Guiraudon G, Klein GJ. Sensitivity and specificity of invasive and non-invasive tests for risk of sudden death in Wolff-Parkinson-White syndrome. Journal of the American College of Cardiology 10: 373–381, 1987

    Article  PubMed  CAS  Google Scholar 

  • Shen EN, Keung E, Huycke E, Dohrmann ML, Nguyenn N, et al. Intravenous propafenone for termination of reentrant supraventricular tachycardia: a placebo controlled randomized, double-blind, cross-over study. Annals of Internal Medicine 105: 655–661, 1986

    PubMed  CAS  Google Scholar 

  • Sherf L, Neufeld H (Eds) The pre-excitation syndrome: facts and theories. Yorke Medical Books, New York, 1978

    Google Scholar 

  • Singer I, Kupersmith J. Nonpharmacological therapy of supraventricular arrhythmias: surgery and catheter ablation techniques. Part II. Pacing and Clinical Electrophysiology 13: 1173–1183, 1990

    Article  PubMed  CAS  Google Scholar 

  • Singh BN, Deedwania P, Nademanee K, Ward A, Sorkin EM. Sotalol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use. Drugs 34: 311–349, 1987

    Article  PubMed  CAS  Google Scholar 

  • Strasberg B, Ashkey WW, Wyndham CRC, Bauernfeind RA, Swyrin SP, et al. Treadmill exercise testing in the Wolff-Parkinson-White syndrome. American Journal of Cardiology 45: 742–748, 1980

    Article  PubMed  CAS  Google Scholar 

  • Sung RJ, Castellanos A, Mallon SM, Bloom MG, Gelband H, et al. Mechanism of spontaneous alternation between reciprocating tachycardia and atrial flutter-fibrillation in the Wolff-Parkinson-White syndrome. Circulation 56: 409–416, 1977

    Article  PubMed  CAS  Google Scholar 

  • Swiderski J, Less MH, Nadas AS. The Wolff-Parkinson-White syndrome in infancy and childhood. British Heart Journal 24: 561–580, 1962

    Article  PubMed  CAS  Google Scholar 

  • Touche M, Touche S, Jouvet M, Leonard J. Elements de pronostic dans le syndrome de Wolff-Parkinson-White. Presse Medicale 76: 567–570, 1968

    PubMed  CAS  Google Scholar 

  • Waldo AL, Akhtar M, Benditt G, Brugada P, Camm AJ, et al. Appropriate electrophysiologic study and treatment of patients with the Wolff-Parkinson-White syndrome. Pacing and Clinical Electrophysiology 11: 536–543, 1988

    Article  PubMed  CAS  Google Scholar 

  • Warin JF, Haissaguerre M. Electrical catheter ablation of accessory pathways: technique and result in 215 patients. Cardiostim 90 7th International Congress. Abstract. RBM Revue Europenne de Tecnologie Biomedicale 12: 143, 1990

    Google Scholar 

  • Wellens HJ. Wolff-Parkinson-White syndrome. Diagnosis, arrhythmias and identification of the high risk patient. Modern Concepts of Cardiovascular Disease 52: 53–56, 1983

    Google Scholar 

  • Wellens HJ, Bar FW, Gorgels AP, Vanagt EJ. Use of ajmaline in patients with the Wolff-Parkinson-White syndrome to disclose short refractory period of the accessory pathway. American Journal of Cardiology 45: 130–133, 1980

    Article  PubMed  CAS  Google Scholar 

  • Wellens HJ, Braat S, Brugada P, Gorgels AP, Bar FW. Use of procainamide in patients with the Wolff-Parkinson-White syndrome to disclose short refractory period of the accessory pathway. American Journal of Cardiology 50: 1087–1089, 1982a

    Article  PubMed  CAS  Google Scholar 

  • Wellens HJ, Brugada P, Roy D, Weiss J, Bar FW. Effect of isoproterenol on the anterograde refractory period of the accessory pathway in patients with Wolff-Parkinson-White syndrome. American Journal of Cardiology 50: 180–184, 1982b

    Article  PubMed  CAS  Google Scholar 

  • Wellens HJ, Durrer D. Wolff-Parkinson-White syndrome and atrial fibrillation: relation between refractory period of accessory pathway and ventricular rate during atrial fibrillation. American Journal of Cardiology 34: 777–782, 1974

    Article  PubMed  CAS  Google Scholar 

  • Zardini M, De Ponti R, Storti C, Minzioni G, Viganò R, et al. Sindrome di Wolff-Parkinson-White: esperienza di trattamento chirurgico in 100 pazienti. Abstract. Giornale Italiano di Cardiologia 20: (Suppl. 1): 178, 1990

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Ospedale Civile di Asti e Istituto di Medicina e Chirurgia Cardiovascolare, Università di Torino, Via Lamarmora, c 31, 10128, Torino, Italy

    Fiorenzo Gaita, Carla Giustetto, Riccardo Riccardi & Antonio Brusca

Authors
  1. Fiorenzo Gaita
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Carla Giustetto
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Riccardo Riccardi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Antonio Brusca
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gaita, F., Giustetto, C., Riccardi, R. et al. Wolff-Parkinson-White Syndrome. Drugs 43, 185–200 (1992). https://doi.org/10.2165/00003495-199243020-00005

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-199243020-00005

Keywords

Search

Navigation